Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Post by Insightful1on Mar 15, 2022 1:47am
171 Views
Post# 34514002

UK Health Partners on linkedin

UK Health Partners on linkedinhttps://www.linkedin.com/company/healthpartnersgroup/

UK Health Partners is starting their social media acknowledgement of the  MedX pilot. It is interesting to note the managing director noted; The pilot programme will span three to six months and involve an estimated 600 patients across two of our sites. If the pilot is successful, the plan is to roll out the MedX DermSecure® Screening Platform to our more than 2M patients across the UK and the Republic of Ireland. 

Of course MedX has to deliver during the paid pilot but if successful this opens MedX to a large patient population. It is interesting the people who liked this post are clearly influencers in this space. I think if MedX can start turning pilots into commercial agreements that will be the next indicator they are gaining revenue driven traction. 
<< Previous
Bullboard Posts
Next >>